BIMI International Medical Inc. Announces Results of Special Meeting
November 08 2021 - 4:30PM
BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the
“Company”), a leading healthcare products and services provider,
today announced that shareholders have approved the two
proposals voted on at the Registrant’s special meeting of
shareholders held on November 5, 2021.
The first proposal is an amendment to the Registrant’s
Certificate of Incorporation to increase the number of Registrant’s
authorized shares of common stock (the “Common Stock”) by
150,000,000 to 200,000,000. The second proposal is that the
shareholders grant discretionary authority to the board of
directors of the Registrant (the “Board”) to amend the Registrant’s
Certificate of Incorporation to effect a reverse stock split of the
Common Stock within the range of 1-2 to 1-5 to be determined by the
Board and with the reverse stock split to be effective at such time
and date, if at all, as determined by the Board, but not later than
the first anniversary of its approval by the Shareholders.
“I would like to thank our shareholders for their support in
approving the two proposals. Increasing the number of common shares
will allow us to have sufficient shares to support future
transactions”, said Mr. Tiewei Song, Chief Executive Officer and
President of BIMI International Medical Inc.
About BIMI International Medical Inc.
BIMI International Medical Inc. was founded in 2006. The Company
is now exclusively a healthcare products and provider, offering a
broad range of healthcare products and related services and
operates five private hospitals in China. For more information,
please visit www.usbimi.com.
Safe Harbor Statement
Certain matters discussed in this news release are
forward-looking statements that involve a number of risks and
uncertainties including, but not limited to, the Company’s ability
to achieve profitable operations, its ability to continue to
operate as a going concern, its ability to continue to meet NASDAQ
continued listing requirements, the effects of the spread of
COVID-19, the demand for the Company’s products and services in the
People’s Republic of China, general economic conditions and other
risk factors detailed in the Company’s annual report and other
filings with the United States Securities and Exchange
Commission.
IR Contact:
Dragon Gate Investment Partners LLC Tel: +1(646)-801-2803
Email: BIMI@dgipl.com
BIMI International Medical (NASDAQ:BIMI)
Historical Stock Chart
From Mar 2024 to Apr 2024
BIMI International Medical (NASDAQ:BIMI)
Historical Stock Chart
From Apr 2023 to Apr 2024